baber/WOPTO huggingface dataset:
Patent MX-2013002238-A (MX)
Title: Sanitary fittings.
Inventor: BALKAU MATTHIAS
IPC: F16K11/20
Filed: 2013-02-26
Abstract: The sanitary fitting has a fitting housing (1) which is provided with outlet element (8) and shut-off valve. An actuating element is provided for actuating the shut-off valve and outlet element. The actuating element is formed as a sleeve which is grasped by user so as to be rotatable with respect to its own axis independently of the outlet element. The discharge element is arranged in sleeve.
Patent MX-2013003125-A (MX)
Title: Land seismic cable and method.
Inventor: COSTE EMMANUEL
IPC: G01V1/16
Filed: 2011-08-15
Abstract: A seismic cable for use in land applications is described. The cable includes seismic sensors for measuring seismic signals reflected from subterranean or subsea formations. The cable may be deployed in trenches dug in the survey region to provide adequate sensor coupling to ground. Sensor units may be inline with the cable and may further be disposed in slim casings, thus facilitating handling and deployment.
Patent MX-2013004541-A (MX)
Title: Corner patches and methods for tpo roofing.
Inventor: RAILKAR SUDHIR
IPC: E04D13/14
Filed: 2013-04-23
Abstract: An outside corner patch for TPO roofing is formed from a circular piece of TPO membrane material being vacuum formed to define an array of flutes that extend from the center of the piece toward its edges. The flutes form ridges and valleys that generally are shaped as conical sections with the apex of the conical sections located at the center of the patch. The number and size of the flutes is optimized in such a way that, when the flutes are stretched flat, the patch conforms to and fits flat against the surfaces of an outside corner formed by the intersection of a roof deck with an upward protrusion from the roof. The TPO outside corner patch is applied over the corner and thermally welded to surrounding TPO membranes on the roof deck and the protrusion to form a watertight seal at the outside corner.
Patent MX-2013007123-A (MX)
Title: Manifold for controlling airflow within an explosion-proof enclosure.
Inventor: MANAHAN JOSEPH MICHAEL
IPC: F24F8/10
Filed: 2011-12-20
Abstract: A manifold within an explosion-proof enclosure is described herein. The manifold can include an inlet duct coupled to an air moving device, where the inlet duct can receive exhaust air from the air moving device. The manifold can further include an outlet duct that includes a perimeter and at least one channel, where the outlet duct can send the exhaust air outside the explosion-proof enclosure, where the perimeter of the outlet duct is coupled to a first portion of an inner surface of an outer wall of the explosion-proof enclosure, and where the first portion of the inner surface includes at least one aperture that traverses the outer wall. The manifold can also include a body that includes a cavity, where the body couples the inlet duct to the at least one channel, and where the exhaust air flows from the inlet duct through the cavity to the outlet duct.
Patent MX-2013008496-A (MX)
Title: Pasteurisation tunnel and pasteurisation method for beverage containers.
Inventor: KRAUSE HANS-JOACHIM
IPC: B65D1/00
Filed: 2013-07-22
Abstract: A pasteurization tunnel and a method for pasteurizing beverage packs are described, wherein the beverage packs are conveyed on at least two decks lying one upon the other and sprayed with a heated spraying liquid from spraying pipes extending each transversely to the conveying direction of the beverage packs. According to the invention, the spraying liquid is guided through the spraying pipes of the one deck into the spraying pipes of the other deck. Thereby, the maintenance efforts for removing deposits in sections of the spraying pipes where the flow is weak can be reduced.
Patent MX-2013010272-A (MX)
Title: Wall insulation system with blocks having angled sides.
Inventor: MCCLURE RICHARD R
IPC: E04B2/56
Filed: 2012-03-09
Abstract: Wall systems and methods for making such wall systems are disclosed herein. According to one embodiment, a wall system comprises a plurality of vertically displaced horizontal support members, and a wall panel having at least one inwardly-extending ridge. The wall system also includes at least two foam insulation blocks. Each block has a surface that is adapted to conform to the shape of the inwardly-extending ridge of the wall panel. The blocks are spaced apart along each of the horizontal support members and are fastened between the panel and the support member. The spacing created by the blocks allows for a blanket of insulation between the blocks and the support members to expand, improving the system's insulative properties.
Patent MX-2013013098-A (MX)
Title: Methods and compositions for promoting lean body mass growth.
Inventor: PAN YUANLONG
IPC: A01N37/18
Filed: 2012-05-08
Abstract: The invention provides methods for promoting lean body mass growth in an animal. The methods comprise administering OEA to the animals, preferably in amounts of from about 0.01 to about 1000 mg/kg/day.
Patent MX-2013013853-A (MX)
Title: Pyrazole derivatives.
Inventor: GALLEY GUIDO
IPC: C07D413/14
Filed: 2012-06-06
Abstract: The invention relates to compounds of formula wherein R1 is hydrogen or phenyl, optionally substitutes by halogen, CN or lower alkoxy or lower alkoxy substituted by halogen; R2 is hydrogen or lower alkyl; R3 is hydrogen or lower alkyl or is phenyl optionally substituted by one or more substituents, selected from halogen, cyano or lower alkoxy substituted by halogen, or is pyridinyl, optionally substituted by halogen or lower alkyl substituted by halogen, or is pyrimidinyl, optionally substituted by lower alkyl substituted by halogen, or is pyrazinyl, optionally substituted by halogen, cyano or lower alkyl substituted by halogen; R4 is hydrogen, lower alkyl or phenyl; Z is a bond, -CH2- or -O-; or to a pharmaceutically suitable acid addition salt thereof. It has now been found that the compounds of formulas IA and IB have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
Patent MX-2013013873-A (MX)
Title: Height control valve assembly for axle/suspension systems.
Inventor: YAGIELA MICHAEL W
IPC: B60G11/26
Filed: 2012-06-14
Abstract: A height control valve assembly for an axle/suspension system of a vehicle includes a height control valve in fluid communication with a compressed air source, with at least one air spring of said vehicle, and with atmosphere. The height control valve is attached to the frame of the vehicle and includes a flow control means for regulating fluid flow through the valve. A control arm is operatively attached to the flow control means, whereby movement of the control arm regulates fluid flow through the height control valve. The height control valve assembly further includes a link having a first end and a second end. The first end of the link is operatively attached to the control arm. The second end of the link is attached to the beam of the axle/suspension system, such that the ends of the link are generally vertically aligned.
Patent MX-2014002163-A (MX)
Title: Methods for treating cardiovascular disorders.
Inventor: KODGULE MANDAR MADHUKAR
IPC: A61K31/135
Filed: 2012-08-23
Abstract: There is provided a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form comprises a fixed dose combination of metoprolol in extended release form and one or more calcium channel blocker, angiotensin II receptor blocker or angiotensin converting enzyme inhibitor along with one or more rate controlling excipient.
Patent MX-2014004020-A (MX)
Title: Solar heater.
Inventor: VALDES JOSE ELIAS HUMBERTO MARTIN
IPC: F24J2/44
Filed: 2014-04-03
Abstract: The present invention consists in the design of a solar heater with an operation different from conventional devices, which uses glass tubes with a heater element and storing tank. The invention may capture the heat in a direct manner from the solar radiation so as to remove the use of fossil fuels and the consequent emission of residual gas. The invention has a compact design, with no glass elements, having a higher capacity to convert the heat received from the solar radiation into a higher water temperature. The invention includes a chassis that simultaneously acts as water pre-heater; a metallic heat exchanger; a stainless tank for hot water conventionally insulated for preserving the water temperature; a transparent cover for allowing the infra-red solar spectrum of the solar radiation to pass, acting as a primary heating element; a thermochemical valve for automating the equipment, allowing the hot water to flow to the tank, only when this valve receives temperature from the sol ar radiation.
Patent MX-2014006338-A (MX)
Title: Method for obtaining noni juice (morinda citrifolia l.) by exogenous enzymes.
Inventor: MOLINA OFELIA MARQUEZ
IPC: A23L2/04
Filed: 2014-05-27
Abstract: The present invention refers to the obtention of noni juice by the application of exogenous enzymes. The process for obtaining said juice is intended to increase the concentration of phenolic compounds (up to 36 times compared to concentrations of previous processes).
Patent MX-2014006686-A (MX)
Title: Novel pyrrole derivatives.
Inventor: HIRST SIMON CHRISTOPHER
IPC: C07D407/04
Filed: 2012-12-05
Abstract: There are provided inter alia compounds of formula (I) wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Patent MX-2014007384-A (MX)
Title: Combination lock.
Inventor: KNOLL YEHONATAN
IPC: E05B67/36
Filed: 2012-12-20
Abstract: A combination lock comprising a housing having an lodge port configured for removably receiving therein a shank; a locking bar received within the housing and having a shank port. The locking bar is configured for displacing at least between an open position in which the shank port is aligned with the lodge port to allow a locking portion of the shank to displace into the housing through both ports, and a securing position in which the shank port is misaligned with the lodge port to prevent the locking portion of the shank from displacing outside the housing via the shank port; a combination mechanism associated with the locking bar and configured for switching between at least an unlocked position in which the locking bar is free to displace from its closed position to its open position, and a locked position in which the locking bar is arrested; a securing arrangement constituted by an arresting member of the locking bar configured for interlocking engagement with an arresting portion of the housing, and a biasing mechanism for urging the locking bar into the interlocking engagement with the arresting portion of the housing, the securing arrangement being configured, when the locking portion of the shank is dislodges from the lodge port, for preventing displacement of the locking bar from its open position.
Patent MX-2014013457-A (MX)
Title: Automated batch control of delayed coker.
Inventor: LUCAS RICHARD E
IPC: C10B41/00
Filed: 2013-05-09
Abstract: An automatic batch sequence computer control system is configured to automatically operate process valves in a delayed coker for a complete coke drum cycle. Double verification of the movement of the process valves is used to confirm advancing to the next step. Primary verification is achieved by using position sensors on the valves. Secondary verification is achieved by using monitored process conditions and confirming the measured conditions correlate with expected process conditions for an arrangement of valve positions at a given sequence in the coke drum cycle. A safety interlock system may be integrated with the control system.
Patent MX-2014013725-A (MX)
Title: Compositions and methods of obtaining and using endoderm and hepatocyte cells.
Inventor: DOUDEMENT ESTELLE
IPC: C12N5/071
Filed: 2013-05-21
Abstract: The invention provides for efficient methods for generating populations of endoderm cells and/or differentiated cells derived from endoderm cells (e.g., hepatic cells, pancreatic precursor cells, pancreatic cells, intestinal progenitor cells, intestinal cells, lung progenitor cells, lung cells, etc.). Also provided are compositions of endoderm cells and differentiated cells derived from endoderm cells (e.g., hepatic cells, pancreatic precursor cells, pancreatic cells, intestinal progenitor cells, intestinal cells, lung progenitor cells, lung cells, etc.) and methods of using such cells.
Patent MX-2014015096-A (MX)
Title: Crustacean feed.
Inventor: OHARA TAKAAKI
IPC: A23K1/16
Filed: 2013-06-26
Abstract: The present invention addresses the problem of providing a method whereby viral infectious diseases in crustacean can be prevented and/or treated without using antibiotics, and a feed for preventing and/or treating viral infectious diseases. The method for preventing and/or treating viral infectious diseases in crustacean according to the present invention is characterized by comprising administering to crustacean coenzyme Q, said coenzyme Q containing 50% or more of coenzyme Q10 relative to the total coenzyme Q, in a dose of 1.2-8 mg/day per kg body weight. The feed for preventing and/or treating viral infectious diseases in crustacean according to the present invention is characterized by comprising, as an active ingredient, 1 ppm or more of coenzyme Q, said coenzyme Q containing 50% or more of coenzyme Q10 relative to the total coenzyme Q, and being to be administered in such a manner that the coenzyme Q that is the active ingredient is administered in a dose of 1.2-8 mg/day per kg body weight.
Patent MX-2014015704-A (MX)
Title: Polymer blend comprising propylene-based elastomer and random copolymer polypropylene.
Inventor: FREI FABIAN
IPC: C08J5/18
Filed: 2013-06-21
Abstract: Composition comprising as the polymer base - around 40 to 75% w/w of at least one polypropylene-based elastomer and - around 25 to 60% w/w of at least one random copolymer polypropylene.
Patent MX-2015000947-A (MX)
Title: Polyurethane coating agent composition and use thereof, multi-stage coating methods.
Inventor: HOFFMANN PETER
IPC: C08G18/62
Filed: 2013-06-04
Abstract: The present invention relates to non-aqueous coating agent compositions containing (A) at least one polyhydroxyl group-containing compound, (B) at least one polyisocyanate group-containing compound having free or blocked isocyanate groups, (D) at least one phosphoric acid or phosphonic acid compound blocked with an amine as a catalyst (D), and (S) at least one monomeric aromatic, optionally substituted carboxylic acid (S), the carboxyl group of which is in conjugation with a Ï-electron system, wherein the component (B) contains at least one structural unit -NR-(X-SiR''x(OR')3-x) (II) and/or at least one structural unit -N(X-SiR''x(OR')3-x)n(X'-SiR''y(OR')3-y)m (III). The present invention further relates to multi-stage coating methods and to the use of the coating agent compositions.
Patent MX-2015001104-A (MX)
Title: Systems and methods for semi-persistent scheduling of wireless communications.
Inventor: ZHU YUAN
IPC: H04W72/04
Filed: 2013-09-25
Abstract: Methods, systems, and devices for transmission and reception of SPS communications are disclosed herein. User equipment (UE) is configured to receive, in a first subframe, a physical downlink control channel or enhanced physical downlink control channel (PDCCH/EPDCCH) corresponding to semi-persistent scheduling (SPS) activation. The PDCCH/EPDCCH conveys a value of nSCID. The UE configures, based on the SPS activation, a downlink (DL) assignment in a second subframe for receiving an SPS physical downlink shared channel (PDSCH) without a corresponding PDCCH/EPDCCH. The UE determines a reference signal sequence corresponding to the SPS PDSCH using nSCID derived from the PDCCH/EPDCCH corresponding to the associated SPS activation. The UE receives the SPS PDSCH in a second subframe. The UE processes the SPS PDSCH based on the reference signal sequence for the SPS PDSCH in the second subframe using the nSCID derived from the PDCCH/EPDCCH corresponding to the associated SPS activation. The UE is configured for transmission mode 10 (TM10).
Patent MX-2015001302-A (MX)
Title: Micro proppants for far field stimulation.
Inventor: SAINI RAJESH KUMAR
IPC: C09K8/62
Filed: 2013-07-31
Abstract: A subterranean zone surrounding a well bore is fractured with a fracturing fluid. Micro proppant of 200 mesh or smaller is pumped into far field fractures of the subterranean zone and props the far field fractures open.
Patent MX-2015002660-A (MX)
Title: Controlled delivery drive mechanisms for drug delivery pumps.
Inventor: BOKELMAN KEVIN
IPC: A61M5/145
Filed: 2013-08-29
Abstract: A controlled delivery drive mechanism includes a drive housing, a piston, and a biasing member initially retained in an energized state and is configured to bear upon an interface surface of the piston. The piston is configured to translate a plunger seal and a barrel. A tether is connected between the piston and the winch drum to restrain the free expansion of the biasing member and the free axial translation of the piston upon which the biasing member bears upon. The drive mechanism may further include a gear assembly having a motor configured to drive the gear assembly to release the tether from the winch drum. The metering of the tether by the motor controls the rate or profile of drug delivery to a user. A drug delivery pump includes such a controlled delivery drive mechanism. A control system may be utilized to control the desired drug delivery rate/profile.
Patent MX-2015004615-A (MX)
Title: Serine/threonine kinase inhibitors.
Inventor: WANG SHUMEI
IPC: A61P35/00
Filed: 2013-10-15
Abstract: Compounds having the formula (I) wherein R1and R2 are as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
Patent MX-2015006132-A (MX)
Title: Jacket composition for riser and plenum cables.
Inventor: BROWN SCOTT M
IPC: H01B3/00
Filed: 2013-11-14
Abstract: The present invention relates to materials for making cable jackets, particularly for riser and plenum cables. The materials provide low flammability and allow the cable to meet UL 910 or NFPA-262 or UL 1666 specifications. The composition contains polyvinyl chloride (PVC) resin, a plasticizer, ammonium octamolybdate, a molybdate compound, a stabilizer, a lubricant, aluminum trihydrate, and either i) metal oxide particles, ii) a polytetrafluoroehtylene (PTFE), iii) an intumescent compound, or iv) combinations thereof.
Patent MX-2015009867-A (MX)
Title: Factor x mutants.
Inventor: PLANTIER JEAN-LUC
IPC: C12N9/64
Filed: 2014-02-03
Abstract: The present invention concerns a protein comprising a mutated sequence of SEQ ID NO: 1, said mutated sequence of SEQ ID NO: 1 comprising at least one mutation A, A', B, C or C, in which: mutation A consists of substituting amino acids 43 to 52 of sequence SEQ ID NO: 1 with a sequence chosen from DFLAEGLTPR, KATN*ATLSPR and KATXATLSPR, mutation A' consists of substituting amino acids 47 to 52 of sequence SEQ ID NO: 1 with a sequence chosen from TSKLTR, FNDFTR, LSSMTR, PPSLTR and LSCGQR, mutation B consists of inserting a sequence chosen from DFLAEGLTPR, KATN*ATLSPR, KATXATLSPR, TSKLTR, FNDFTR, LSSMTR, PPSLTR and LSCGQR, between amino acids 52 and 53 of sequence SEQ ID NO: 1, mutation C consists of inserting a sequence chosen from DFLAEGLTPR, KATN*ATLSPR and KATXATLSPR, between amino acids 52 and 53 of sequence SEQ ID NO: 1, and of deleting amino acids 4 to 13 from sequence SEQ ID NO: 1, mutation C consists of inserting a sequence chosen from TSKLTR, FNDFTR, LSSMTR, PPSLTR and LSCGQR, between amino acids 52 and 53 of sequence SEQ ID NO: 1, and of deleting amino acids 4 to 9 from sequence SEQ ID NO: 1.
Patent MX-2015010169-A (MX)
Title: Optical assemblies with managed connectivity.
Inventor: PETERSEN CYLE D
IPC: G02B6/36
Filed: 2014-02-05
Abstract: An adapter assembly includes a single-piece or two-piece multi-fiber adapter defining a recess at which a contact assembly is disposed. The adapter assemblies can be disposed within adapter block assemblies or cassettes, which can be mounted to moveable trays. Both ports of the adapters disposed within adapter block assemblies are accessible. Only one port of each adapter disposed within the cassettes are accessible. Circuit boards can be mounted within the block assemblies or cassettes to provide communication between the contact assemblies and a data network.
Patent MX-2015011601-A (MX)
Title: Argon beam assisted electrosurgery pencil with smoke evacuation.
Inventor: COSMESCU IOAN
IPC: A61B18/00
Filed: 2014-03-06
Abstract: A surgical pencil that enables simultaneous cutting with an electrode and coagulating with a coagulating material while also performing smoke evacuation. Several different sources of energy can be used for both open procedures and laparoscopy including electrosurgery and argon beam coagulation. In argon beam coagulation (ABC), current is applied to tissue by a directed beam of ionized argon gas which causes a uniform and shallow coagulation surface thereby stopping blood loss.
Patent MX-2015013181-A (MX)
Title: Human pac1 antibodies.
Inventor: HAMBURGER AGNES EVA
IPC: A61K39/395
Filed: 2014-03-14
Abstract: Antibodies and antigen-binding fragments thereof that bind to human PAC1 are provided. Nucleic acids encoding the antibodies and antigen-binding fragments thereof, vectors, and cells encoding the same are also provided. The antibodies and antigen-binding fragments thereof can inhibit binding of PAC1 to PACAP, and are useful in a number of PAC1 related disorders, including the treatment and/or prevention of headache disorders, including migraine and cluster headache.
Patent MX-2015014009-A (MX)
Title: Method and device for cleaning control particles in a wellbore.
Inventor: SHERRILL RYAN
IPC: F02B37/00
Filed: 2015-10-02
Abstract: The invention concerns a method for cleaning control particles (32) in a wellbore (1) of a subterranean formation (18) to improve the recovery of formation fluids and/or gases, said wellbore (1) comprising a wall (10a) defining a borehole (10), at least one control equipment (30) arranged into said borehole (10) and a plurality of control particles (32) arranged between said control equipment (30) and said wall (10a), said method comprising the steps of generating at least one shock wave (60) nearby said control equipment (30) and propagating said at least one shock wave (60) through said control equipment (30) toward said control particles (32) for cleaning said control particles (32).
Patent MX-2015016295-A (MX)
Title: Controlling flow in downhole operations.
Inventor: MAXEY JASON ERIC
IPC: C09K8/68
Filed: 2013-08-26
Abstract: Systems and methods for controlling flow in downhole operations are described. Systems and methods may include a composition including a fracturing fluid base; one or more ionic compounds; a polymer; a crosslinking agent; and a pH modifier. A breaker may be provided in the composition. The composition may be provided to a formation to control flow, and syneresis may occur.